Table 4.
Approaches to impact evaluation for TB screening interventions (adapted from102)
| Impact being evaluated | Study designs | Expected outputs and examples |
|---|---|---|
| Any high-risk group | ||
| Comparison of performance characteristics between different tests and algorithms | Cross-sectional studies evaluating new TB diagnostics | Estimates sensitivity and specificity; can inform on robustness of new diagnostic systems in resource-poor settings30,31,78 Provides number-needed-to-screen per TB patient diagnosed in different populations |
| HIV care clinics and household contacts | ||
| Direct cohort follow-up to evaluate patient-important outcomes following screening | Cohort studies comparing outcomes according to whether or not/how screened Appropriate comparator populations provided by randomisation (e.g., step-wedge), or historical or non-randomly selected comparison cohorts |
Outcomes post-screening can include numbers diagnosed with TB at and after screen, vital status, retention in care, time to TB treatment58 Cost effectiveness and consequences of false-negative and false-positive screening results can also be assessed |
| Well-defined high TB incidence populations | ||
| Time trends in TB case notification rates compared to non-intervention comparator populations | Time trend analysis for:
|
Need accurate routine case notification system; can be confounded by other changes in routine TB diagnosis/reporting Requires disaggregation of routine case notification data to subdistrict level (unless intervention is district-wide) |
| Time trends in deaths from diagnosed/undiagnosed TB | Aiming for reduced diagnosed +/− undiagnosed TB deaths ideally routine as well as intervention participants | Need complete TB registration and outcome data for diagnosed TB deaths Accurate capture of undiagnosed TB deaths requires autopsy |
| Prevalence surveys for undiagnosed TB in the general population | Repeated before-after, or cluster-randomised cross-sectional outcomes Requires very large sample sizes and consistent survey methods |
Change/difference in undiagnosed TB provides outcome (less is always better). Several recent examples7,22,39,43,107 Before:after change does not prove causality; aim for major change in short time period to provide strongest evidence104 |
| TB transmission rates | Before-after estimates, or cluster randomised cohort or cross-sectional outcomes; requires large sample sizes and consistent methods | Evidence of impact on TB transmission is an ideal outcome, but difficult to measure and so not often evaluated in high TB incidence settings; results affected by HIV status One recent example used an incidence cohort design in schoolchildren22,43 |
| TB prevalence in HIV-infected patients | Assessed through repeated before-after design, regular surveillance with time trends, or cluster-randomised cross-sectional outcomes New clinic attendees, or routine post-mortem |
A key indicator of population-level TB control, and also the main target of prevention for TB-HIV interventions Occurs at high prevalence and clearly linked to TB transmission |
TB = tuberculosis; HIV = human immunodeficiency virus